What is uACR, and what is a normal result?
A uACR is one line on a kidney lab report, and a single number is easy to over- or under-read. Repeat tests and results from different doctors change how it reads.
Arun Verma, co-founder of Triangle · 2026-10-17
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it.
What is uACR?
uACR is a urine test that compares the amount of albumin, a protein, with the amount of creatinine, a waste product, in a urine sample. The letters stand for urine albumin-to-creatinine ratio. A healthy kidney doesn't let albumin pass from the blood into the urine, NIDDK says, and a damaged kidney lets some through. Too much albumin in the urine is called albuminuria. Your lab report may not say uACR. MedlinePlus lists other names, including albumin-creatinine ratio, ACR and microalbumin, urine. The National Kidney Foundation (NKF) says to focus on the result with "ratio" in its name, such as "alb/creat ratio" or "albumin/creat ratio, random urine".
What is a normal uACR result?
Below 30 mg/g. NIDDK calls a urine albumin result of 30 mg/g or less normal and anything above 30 mg/g a possible sign of kidney disease, and KDIGO's lowest albuminuria category, A1, is below 30 mg/g. Lower is better: NIDDK says the less albumin in your urine, the better. Exactly 30 is where the wording splits. NIDDK counts it as normal, A1 stops below it, and KDIGO's criteria for chronic kidney disease list an ACR of 30 mg/g or higher as a marker of kidney damage when it lasts at least 3 months. If a result sits right on the line, a fair question for your nephrologist is which side your lab and your team use.
What do the A1, A2 and A3 categories mean?
They are KDIGO's three albuminuria bands: A1 is below 30 mg/g (normal to mildly increased), A2 is 30 to 300 (moderately increased) and A3 is above 300 (severely increased). KDIGO's table gives the same bands in mg/mmol, as below 3, 3 to 30 and above 30, so it helps to know which unit your report uses. The edges are printed two ways. KDIGO's monitoring grid and NKF say 30 to 299 and 300 or higher. NIDDK's clinician page notes the middle band has traditionally been called microalbuminuria and the top one macroalbuminuria, says the 300 cutoff only roughly matches the lower limit of the dipstick, that the cutoffs come from laboratory methods rather than clinically relevant endpoints, and that urine albumin is a continuous risk factor.
How is the sample taken, and why a ratio?
Usually one urine sample, given at a clinic or lab. KDIGO prefers a first-morning midstream sample. NIDDK's clinician page says a random sample collected in the office is acceptable if a first-morning one isn't available, and that a 24-hour collection isn't necessary for routine assessment. MedlinePlus says a 24-hour sample is usually the follow-up to an abnormal single sample. The ratio is there because urine can be dilute or concentrated. NIDDK's clinician page says that, unlike a dipstick, UACR corrects for variation in urine concentration, and that providers use it to estimate how much albumin would pass into the urine over 24 hours.
Can one uACR result be a blip?
Yes. A single result can be temporary, which is why an abnormal one is usually checked again. KDIGO defines CKD as abnormalities present for at least 3 months and says not to assume chronicity from a single abnormal ACR or eGFR, and MedlinePlus says people usually have two more tests over the next three to six months. Exercise, certain medicines, fever and inflammation can push a single result up, and so can blood in the urine, menstruation and a symptomatic urinary infection. For someone already living with CKD, KDIGO's first step with a change in eGFR or ACR is to repeat the test. You could ask whether anything around the sample, such as a workout or a fever, might have affected it, and whether any medicines or supplements could.
How does uACR fit with eGFR on the CKD staging grid?
Side by side: eGFR sets the G part of the stage and uACR sets the A part. KDIGO classifies CKD by cause, GFR category (G1 to G5) and albuminuria category (A1 to A3), and says the system rests on those two dimensions, so a stage can read like G3a, A1. KDIGO's grid is shaded green, yellow, orange and red for rising risk. KDIGO says risk rises with higher stages of both eGFR and albuminuria, which is why it wants both numbers, and that the grid describes populations and is not an individual risk tool. NKF adds that albumin in the urine can be a sign of kidney disease even when eGFR is above 60.
How often is uACR tested?
KDIGO's practice point is at least once a year in people with CKD, and more often for individuals at higher risk of CKD progression when measurement will impact therapeutic decisions. NKF says follow-up ranges from once a year to four or more times a year, depending on your initial uACR, your eGFR and whether you have been diagnosed. A fair question for your team is when your last uACR was and when the next one is due. NKF's own question list starts with "When was the last time I had a uACR test completed?"
How do I read a trend, or compare results from different doctors?
A trend needs more than one result, and results in different units don't line up directly. KDIGO says no clear threshold defines a clinically relevant change in albuminuria, and that overinterpreting small changes can lead to unnecessary changes in care. It also says that for albuminuria monitoring in people with CKD, a doubling of the ACR on a later test exceeds laboratory variability and warrants evaluation. NIDDK's clinician page says stable or lower levels may indicate therapy is effective and increasing or elevated levels may indicate progression. With results from more than one practice, a fair question for whoever ordered each one is which unit and which kind of sample it used. KDIGO prints the categories in both mg/g and mg/mmol, and says a result of 30 mg/g or higher on a random sample should be confirmed with a later first-morning one.
What could I ask my nephrologist about my uACR?
You could ask whether your latest uACR has been confirmed by a repeat, which category your lab and your team put it in, how it sits with your eGFR on the staging grid, and when the next one is due. NKF's list for your healthcare team includes "Should I have my uACR test repeated to confirm my results?" and "What do my uACR results mean in the context of my overall health?" No source says what a given number means for a given person; that is a question for the people who know your history.
Sources
- NIDDK: Chronic Kidney Disease Tests & Diagnosis (last reviewed October 2016): NIDDK says the urine albumin-to-creatinine ratio (UACR) test measures and compares the amount of albumin with the amount of creatinine in a urine sample, and that albumin is a protein.
- NIDDK: Chronic Kidney Disease Tests & Diagnosis (last reviewed October 2016): NIDDK says creatinine is a waste product from the normal breakdown of muscles in the body.
- NIDDK: Albuminuria: Albumin in the Urine (last reviewed October 2016): NIDDK says a healthy kidney doesn't let albumin pass from the blood into the urine, and a damaged kidney lets some albumin pass into the urine.
- NIDDK: Albuminuria: Albumin in the Urine (last reviewed October 2016): NIDDK says albuminuria means that you have too much albumin in your urine.
- MedlinePlus: Microalbumin Creatinine Ratio: MedlinePlus lists other names for the test: albumin-creatinine ratio, urine albumin, microalbumin (urine), ACR and UACR.
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF says a uACR lab report may show many numbers, to focus on the result with the word ratio in its name, and gives example report names "alb/creat ratio", "albumin/creat ratio" and "albumin/creat ratio, random urine".
- NIDDK: Chronic Kidney Disease Tests & Diagnosis (last reviewed October 2016): NIDDK says a urine albumin result of 30 mg/g or less is normal and more than 30 mg/g may be a sign of kidney disease.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Table 3, p. S137): KDIGO's albuminuria category A1 is below 30 mg/g (below 3 mg/mmol), described as normal to mildly increased (Table 3).
- NIDDK: Albuminuria: Albumin in the Urine (last reviewed October 2016): NIDDK says the less albumin in your urine, the better.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Table 1, p. S137): KDIGO's criteria for chronic kidney disease (either of the following present for a minimum of 3 months) list albuminuria, an ACR of 30 mg/g (3 mg/mmol) or higher, as a marker of kidney damage (Table 1).
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Table 3, p. S137): KDIGO's table of albuminuria categories gives A2 as 30-300 mg/g (3-30 mg/mmol), moderately increased, and A3 as above 300 mg/g (above 30 mg/mmol), severely increased; the table labels the ACR equivalents as approximate (Table 3).
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Figure 13, p. S197): KDIGO's monitoring grid prints the A2 range as 30-299 mg/g and the A3 range as 300 mg/g or higher (Figure 13).
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF gives 30 to 299 mg/g as moderately increased and 300 mg/g or higher as severely increased.
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says that traditionally 30-300 mg/g has been called microalbuminuria and greater than 300 mg/g macroalbuminuria.
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says the 300 mg/g cutoff merely represents a rough correlation with the lower limit of sensitivity of the traditional urine dipstick for albumin, and that the albuminuria cutoffs are derived from laboratory methods rather than clinically relevant endpoints.
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says urine albumin is a continuous risk factor.
- NIDDK: Chronic Kidney Disease Tests & Diagnosis (last reviewed October 2016): NIDDK says you collect the urine sample in a container in a health care provider's office or lab.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 1.3.1.1, p. S154): KDIGO's practice point says that for initial testing of albuminuria a first-void morning midstream sample is preferred in adults (Practice Point 1.3.1.1).
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says the first morning void is preferred and that a random urine sample collected in the office is also acceptable if a first morning void is not available.
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says a 24-hour urine collection is not necessary for routine assessment.
- MedlinePlus: Microalbumin Creatinine Ratio: MedlinePlus says a 24-hour urine sample is usually used to follow up on abnormal results from a test on a single sample of urine.
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says that, unlike a dipstick test for albumin, UACR corrects for variation in urine concentration.
- NIDDK: Chronic Kidney Disease Tests & Diagnosis (last reviewed October 2016): NIDDK says providers use the UACR to estimate how much albumin would pass into the urine over 24 hours.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 1.1.3.2, p. S149): KDIGO's practice point says not to assume chronicity based upon a single abnormal level for eGFR and ACR (Practice Point 1.1.3.2).
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Definition of CKD, p. S137): KDIGO defines CKD as abnormalities of kidney structure or function, present for a minimum of 3 months, with implications for health.
- MedlinePlus: Microalbumin Creatinine Ratio: MedlinePlus says temporary increases in albumin levels may be caused by exercise, certain medicines, fever and inflammation in the body.
- MedlinePlus: Microalbumin Creatinine Ratio: MedlinePlus says people usually have two more tests during the three to six months after the first test.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Table 16, pp. S191–S192): KDIGO's table of factors causing biological variation lists hematuria (blood in the urine), menstruation, exercise and symptomatic urinary infection as increasing albumin and protein in the urine (Table 16).
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Chapter 2.1 rationale, p. S196): KDIGO says the initial evaluation of an observed change in either eGFR or ACR should be to repeat the test(s) to determine whether the change is clinically significant progression or within biological and analytical variability.
- MedlinePlus: Microalbumin Creatinine Ratio: MedlinePlus says to ask your provider whether any medicines or supplements you take could affect your results.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (CKD nomenclature, p. S126): KDIGO says CKD is classified based on Cause, GFR category (G1-G5) and Albuminuria category (A1-A3), abbreviated CGA.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Definition and classification of CKD, p. S137; example notation p. S144): KDIGO says the classification system is based on the 2 dimensions of GFR and degree of albuminuria, and its text writes combined categories as, for example, CKD G3a, A1.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (CKD nomenclature, p. S126): KDIGO's grid is color coded: green is low risk (if no other markers of kidney disease, no CKD), yellow moderately increased risk, orange high risk and red very high risk.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Summary of relative and absolute risks, p. S144): KDIGO says that within the CKD population the association of risk for all 10 outcomes it examined increases with higher stages of both eGFR and albuminuria, and that the figures show the necessity of having both eGFR and ACR available in assessing risk.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Summary of relative and absolute risks, p. S144): KDIGO says the risk distributions across CKD categories are at a population level and are not to be confused with the individualized risk assessment tools described in its Chapter 2.
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF says having albumin in your urine can be a sign of kidney disease even if your eGFR is above 60 or "normal".
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 2.1.1, p. S196): KDIGO's practice point says to assess albuminuria and GFR at least annually in people with CKD (Practice Point 2.1.1).
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 2.1.2, p. S196): KDIGO's practice point says to assess albuminuria and GFR more often for individuals at higher risk of CKD progression when measurement will impact therapeutic decisions (Practice Point 2.1.2).
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF says the recommended frequency of follow-up uACR testing ranges from once a year to 4 or more times per year depending on your specific condition, and depends on your initial uACR, your eGFR and whether you have been diagnosed with kidney disease.
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF's list of questions for your healthcare team begins with "When was the last time I had a uACR test completed?"
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 2.1.1 rationale, p. S196): KDIGO says no clear threshold defines a clinically relevant change in GFR or albuminuria.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 2.1.1 rationale, p. S196): KDIGO says overinterpretation of small changes in GFR or albuminuria may lead to unnecessary changes in clinical management.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 2.1.5, p. S197): KDIGO's practice point says that for albuminuria monitoring of people with CKD a doubling of the ACR on a subsequent test exceeds laboratory variability and warrants evaluation, and its rationale says small fluctuations in albuminuria may not indicate disease progression (Practice Point 2.1.5).
- NIDDK: Assess Urine Albumin, clinical tools for health professionals (last reviewed March 2012): NIDDK's clinician page says stable or lower levels of albuminuria may indicate therapy is effective, and increasing or elevated levels may indicate progression of CKD.
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease, Kidney Int 2024;105(4S) (Practice Point 1.3.1.2, p. S154): KDIGO's practice point says to confirm an ACR of 30 mg/g or higher on a random untimed urine with a subsequent first morning void in the morning midstream urine sample (Practice Point 1.3.1.2).
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF's list of questions for your healthcare team includes "Should I have my uACR test repeated to confirm my results?"
- National Kidney Foundation: Urine albumin-creatinine ratio (uACR) (last updated May 1, 2023): NKF's list of questions for your healthcare team includes "What do my uACR results mean in the context of my overall health?"
Start your 7-day free trialBasin is made by Triangle. 7-day free trial, then $9 a month. Cancel anytime.